# TriRx Huntsville Pharmaceutical Services, LLC - Inspection Records

Source: https://www.keypedia.com/companies/trirx-huntsville-pharmaceutical-services-llc/bdf3220b-2a57-4125-b4ef-af4d1d9c9fa8

> Inspection records and compliance data for TriRx Huntsville Pharmaceutical Services, LLC in Huntsville, Alabama. Access full analysis and detailed observations.

---

## Details

- Name: TriRx Huntsville Pharmaceutical Services, LLC
- FEI Number: 3003197096
- City: Huntsville
- State: Alabama
- Country Name: United States
- Address Line 1: 120 Vintage Dr Ne
- Zip Code: 35811
- Business Operations: API/FDF ANALYTICAL TESTING, FDF MANUFACTURE, PACK

## Related Documents

- [FDA Inspection 1216782 - TriRx Huntsville Pharmaceutical Services, LLC - 2023-08-11](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/3b33daf8-bfa6-437e-9d8f-1611b733a98f) — classification: No Action Indicated (NAI), source: FDA, date: August 11, 2023
- [483 - TriRx Huntsville Pharmaceutical Services, LLC - 2022-04-01](https://www.keypedia.com/records/483/trirx-huntsville-pharmaceutical-services-llc/3cc0cfca-da41-428e-b501-67cd70f9d2ae) — source: FDA, date: April 1, 2022
- [FDA Inspection 1166895 - TriRx Huntsville Pharmaceutical Services, LLC - 2022-04-01](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/3f8dc216-6d17-4b5b-a74a-14052c6e9579) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 1, 2022
- [FDA Inspection 978625 - TriRx Huntsville Pharmaceutical Services, LLC - 2016-04-21](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/89ab6faa-5411-4e35-966a-c29e63d3031b) — classification: No Action Indicated (NAI), source: FDA, date: April 21, 2016
- [483 - TriRx Huntsville Pharmaceutical Services, LLC - 2014-12-19](https://www.keypedia.com/records/483/trirx-huntsville-pharmaceutical-services-llc/fcff31f5-6239-4b24-b66b-0b23a743cdd5) — source: FDA, date: December 19, 2014
- [FDA Inspection 908381 - TriRx Huntsville Pharmaceutical Services, LLC - 2014-12-19](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/0fc0cd41-2f65-4177-ad00-19793dfbefed) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 19, 2014
- [FDA Inspection 891076 - TriRx Huntsville Pharmaceutical Services, LLC - 2014-08-01](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/2d1caa8e-ca78-44d1-9156-75f72a2a356a) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 1, 2014
- [FDA Inspection 888276 - TriRx Huntsville Pharmaceutical Services, LLC - 2014-07-17](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/24d9ed6b-308e-463f-aa5d-65b1c35c9c70) — classification: No Action Indicated (NAI), source: FDA, date: July 17, 2014
- [FDA Inspection 833545 - TriRx Huntsville Pharmaceutical Services, LLC - 2013-05-30](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/9469a83d-564d-4d41-9ab1-b65086f1597b) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 30, 2013
- [FDA Inspection 824161 - TriRx Huntsville Pharmaceutical Services, LLC - 2013-03-21](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/259d905f-1bb1-47fe-acfb-9235528ead4a) — classification: No Action Indicated (NAI), source: FDA, date: March 21, 2013
- [FDA Inspection 761267 - TriRx Huntsville Pharmaceutical Services, LLC - 2011-12-07](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/002658e5-2eb3-4d1e-a729-ce95f7db4e4d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 7, 2011
- [FDA Inspection 721339 - TriRx Huntsville Pharmaceutical Services, LLC - 2011-04-14](https://www.keypedia.com/records/fda_inspections/trirx-huntsville-pharmaceutical-services-llc/341020b5-3b59-4356-a9d3-1a53a4e6a79f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 14, 2011

## Related Companies

- [Aquestive Therapeutics](https://www.keypedia.com/companies/aquestive-therapeutics/1f8e3576-370b-4aa2-b1d2-6d0faa6c3631)
- [PTI Georgia, LLC](https://www.keypedia.com/companies/pti-georgia-llc/a1dea629-43b4-4dda-963c-1b320b0311a5)
- [Alk-abello, Inc.](https://www.keypedia.com/companies/alk-abello-inc/88a052a0-f653-45ca-a45e-89003e4e8565)
- [Aphena Pharma Solutions-Maryland LLC](https://www.keypedia.com/companies/aphena-pharma-solutions-maryland-llc/97893fd6-3370-41f2-95ce-17928ab057e2)
- [OXYGEN DEVELOPMENT, L.L.C.](https://www.keypedia.com/companies/oxygen-development-llc/024c27c1-6cfa-4c7b-9daf-9005cbf515b7)
- [Norwich Pharmaceuticals, Inc.](https://www.keypedia.com/companies/norwich-pharmaceuticals-inc/24e5093f-2fde-40ab-a0a9-518fb46c4bfd)
- [Quality Packaging Specialists International, LLC](https://www.keypedia.com/companies/quality-packaging-specialists-international-llc/74a9861b-efac-463e-b6f9-bd1e22db674a)
- [Lannett Company Inc.](https://www.keypedia.com/companies/lannett-company-inc/d4d7f04f-0ec5-4f5a-868b-d48963202cc8)
- [AML Riverside, LLC](https://www.keypedia.com/companies/aml-riverside-llc/1e839f8a-1cf4-48cd-90e1-62e3a2de0ca6)
- [Lusomedicamenta Sociedade Tecnica Farmaceutica S.A](https://www.keypedia.com/companies/lusomedicamenta-sociedade-tecnica-farmaceutica-sa/f5b2b06c-020e-4078-9766-b6b28bc61e65)

## Related Officers

- [Brandon C. Heitmeier](https://www.keypedia.com/people/brandon-c-heitmeier/09e1b64b-01de-4f8b-819a-1179d8b4c0c1)
- [Libia Lugo](https://www.keypedia.com/people/libia-lugo/55f1387e-b6bd-41ca-8507-45829629dac5)
- [Medical Officer at FDA](https://www.keypedia.com/people/brittny-c-cargo/a3479241-5390-4ddb-b892-df0bac1c89cf)